Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PProcessa Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Processa Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
    Sep 1, 2026Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
    Sep 1, 2026Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
    Sep 1, 2026Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
    Jul 29, 2026Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
    Jul 29, 2026Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
    Jul 29, 2026Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • Vidya Therapeutics Acquisition Presentation
    Jul 29, 2026Processa Pharmaceuticals, Inc. (PCSA) Presentations
  • Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
    Jan 12, 2026Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
    Jan 5, 2026Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
    Dec 17, 2025Processa Pharmaceuticals, Inc. (PCSA) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions